The Latest Cardiac and Vascular News
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company’s strategy to address coronary and peripheral disease MARLBOROUGH, Mass., Jan. 8, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today…
Bolt Medical completes the enrollment of RESTORE ATK pivotal trial for the treatment of peripheral arterial disease with its unique intravascular lithotripsy system. CARLSBAD, Calif., April 22, 2024 /PRNewswire-PRWeb/ — Bolt Medical, Inc., a clinical stage medical device company is…
